NCT05108285View on ClinicalTrials.gov

Dark Halo and MNV: a Study Between ICGA and OCTA

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 1, 2020

Study Completion Date

December 15, 2020

Conditions
Macular Neovascularisation
Interventions
DIAGNOSTIC_TEST

Optical Coherence Tomography Angiography (OCTA) and indocyanine green angiography (ICGA)

OCTA and ICGA is able to detect the dark halo as a area of reduced perfusion around MVN

Trial Locations (1)

80100

"University of Naples Federico II", Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT05108285 - Dark Halo and MNV: a Study Between ICGA and OCTA | Biotech Hunter | Biotech Hunter